Tabrecta, illustration of tablet form (not a photo of the actual pack)

Illustrative image.

Tabrecta

Capmatinib

Prescription required

$50415.00

150mg · 3 × 120 tablets · 6 months supply

BrandBranded medicine· By Novartis

$8402.50 per month

Strength

How long a supply?

6 months$8402.50 a month
Supplied from Israel

Test mode: no payment is taken. View cart

Annual cost

$100830a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

150mg

200mg

About Tabrecta

Overview

Tabrecta is a prescription medicine containing capmatinib, a kinase inhibitor. It treats adults with non-small cell lung cancer that has spread to other parts of the body and has a mutation that causes MET exon 14 skipping, detected by an FDA-approved test. It works by blocking MET, a protein involved in signals that help certain cancer cells grow and survive.

What it treats

Metastatic non-small cell lung cancer (NSCLC) in adults whose tumors have a mutation that causes MET exon 14 skipping, confirmed by an FDA-approved test.

Safety information

Side effects

Common side effects of Tabrecta include swelling, nausea, muscle and bone pain, tiredness, vomiting, shortness of breath, cough and reduced appetite. Serious side effects include lung inflammation (interstitial lung disease or pneumonitis), liver damage, pancreatic toxicity and hypersensitivity reactions. Contact your doctor promptly if you develop new or worsening breathing symptoms or a suspected allergic reaction. Your doctor will monitor liver function and pancreatic enzyme levels. Serious reactions may require treatment to be paused, changed or permanently stopped. Tabrecta may also cause sensitivity to sunlight. Limit direct exposure to ultraviolet light. It can harm an unborn baby; use effective contraception and contact your doctor if you become pregnant.

When to call your doctor

- Seek medical attention immediately for new or worsening shortness of breath or cough. These may be signs of lung inflammation.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Interactions

Avoid taking Tabrecta with medicines that strongly or moderately increase the activity of the enzyme CYP3A (called CYP3A inducers). Ask your doctor whether any medicines you take fall into this group.

Using Tabrecta

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label TABRECTA (CAPMATINIB) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines